Answer ALS is a biological and clinical resource of patient-derived, induced pluripotent stem (iPS) cell lines, multi-omic data derived from iPS neurons and longitudinal clinical and smartphone data from over 1,000 patients with ALS. This resource provides population-level biological and clinical data that may be employed to identify clinical-molecular-biochemical subtypes of amyotrophic lateral sclerosis (ALS). A unique smartphone-based system was employed to collect deep clinical data, including fine motor activity, speech, breathing and linguistics/cognition. The iPS spinal neurons were blood derived from each patient and these cells underwent multi-omic analytics including whole-genome sequencing, RNA transcriptomics, ATAC-sequencing an...
Induced pluripotent stem cells (iPSCs), which are generated through reprogramming adult somatic cell...
The clinical manifestations of amyotrophic lateral sclerosis (ALS) are variable in terms of age at d...
Amyotrophic lateral sclerosis (ALS) is a fatal late-onset motor neuron disease characterized by the ...
Answer ALS is a biological and clinical resource of patient-derived, induced pluripotent stem (iPS) ...
Summary: Neurodegenerative diseases are challenging for systems biology because of the lack of relia...
Neurodegenerative diseases are challenging for systems biology because of the lack of reliable anima...
ALS is a devastating neurodegenerative disorder with no known cure. In this thesis, I describe high-...
Amyotrophic lateral sclerosis is a progressive disease characterized by the loss of upper and lower ...
Amyotrophic lateral sclerosis (ALS) is the most common form of motor neuron disease (MND). It is cur...
Amyotrophic lateral sclerosis is a progressive disease characterized by the loss of upper and lower ...
Amyotrophic lateral sclerosis (ALS) is the most common form of motor neuron disease (MND). It is cur...
Amyotrophic lateral sclerosis (ALS) is the most common form of motor neuron disease (MND). It is cur...
Amyotrophic lateral sclerosis (ALS, MND) is a neurodegenerative disease of upper and lower motor neu...
Motor neuron disease affects 2 in every 100,000 people each year. Amyotrophic lateral sclerosis (AL...
The clinical manifestations of amyotrophic lateral sclerosis (ALS) are variable in terms of age at d...
Induced pluripotent stem cells (iPSCs), which are generated through reprogramming adult somatic cell...
The clinical manifestations of amyotrophic lateral sclerosis (ALS) are variable in terms of age at d...
Amyotrophic lateral sclerosis (ALS) is a fatal late-onset motor neuron disease characterized by the ...
Answer ALS is a biological and clinical resource of patient-derived, induced pluripotent stem (iPS) ...
Summary: Neurodegenerative diseases are challenging for systems biology because of the lack of relia...
Neurodegenerative diseases are challenging for systems biology because of the lack of reliable anima...
ALS is a devastating neurodegenerative disorder with no known cure. In this thesis, I describe high-...
Amyotrophic lateral sclerosis is a progressive disease characterized by the loss of upper and lower ...
Amyotrophic lateral sclerosis (ALS) is the most common form of motor neuron disease (MND). It is cur...
Amyotrophic lateral sclerosis is a progressive disease characterized by the loss of upper and lower ...
Amyotrophic lateral sclerosis (ALS) is the most common form of motor neuron disease (MND). It is cur...
Amyotrophic lateral sclerosis (ALS) is the most common form of motor neuron disease (MND). It is cur...
Amyotrophic lateral sclerosis (ALS, MND) is a neurodegenerative disease of upper and lower motor neu...
Motor neuron disease affects 2 in every 100,000 people each year. Amyotrophic lateral sclerosis (AL...
The clinical manifestations of amyotrophic lateral sclerosis (ALS) are variable in terms of age at d...
Induced pluripotent stem cells (iPSCs), which are generated through reprogramming adult somatic cell...
The clinical manifestations of amyotrophic lateral sclerosis (ALS) are variable in terms of age at d...
Amyotrophic lateral sclerosis (ALS) is a fatal late-onset motor neuron disease characterized by the ...